Enjoy complimentary customisation on priority with our Enterprise License!
The global point of care (POC) HIV testing market size is estimated to grow by USD 290.77 million at a CAGR of 2.91% between 2022 and 2027.
The major key driver of the POC HIV testing market is the early detection and the increasing prevalence of HIV worldwide. HIV is referred to as a viral infection that depletes the immune system, leading to acquired immunodeficiency syndrome (AIDS). The significant reasons why the increasing HIV prevalence drives the demand for POC HIV testing and point of care HIV testing market growth: Increasing HIV Incidence: The number of new HIV infections globally continues to be a major concern. Expanding High-Risk Populations: Certain population groups, such as men who have sex with men (MSM), intravenous drug users, and sex workers, are at a higher risk of contracting HIV. Limited Access to Prevention Measures: Limited access to preventive measures, such as comprehensive sex education, condoms, clean needle exchange programs, and pre-exposure prophylaxis (PrEP), can result in a higher rate of new HIV infections in some regions. The demand for POC HIV testing grows to address existing infections as prevention measures are not universally available or accessible. Such factors are expected to collectively contribute to the increasing prevalence of HIV and drive the demand for POC HIV testing and, in turn, fuel the growth of the market in focus during the forecast period.
Technavio has segmented the market into product, end-user, and geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.
To learn more about this report, Request Free Sample
The market share growth by the POC HIV testing equipment segment will be significant during the forecast period. The devices and instruments used to conduct the HIV test at or near the location where the patient is receiving care shall be referred to as POC HIV testing equipment. Rapid HIV test kits, POC HIV viral load tests, testing systems, and POC CD4 count devices are also included in this equipment. POC HIV testing equipment plays a vital role in expanding access to testing, improving early diagnosis, and increasing linkage to care, particularly in settings with limited laboratory infrastructure or in community-based testing programs.
Get a glance at the market contribution of various segments View a PDF Sample
The POC HIV testing equipment segment was the largest segment and was valued at USD 1,548.81 million in 2017. POC testing equipment has further enhanced the way diagnostics and clinical services are performed. Early HIV diagnostics and rapid initiation of treatment are also important methods implemented by several stakeholders to prevent the spread of HIV. Consequently, technological advances in the form of low-cost rapid POC HIV test equipment have transformed the diagnosis and disease management of HIV. The increasing focus on preventive and early diagnosis programs has boosted the demand for POC HIV testing equipment. Rapid testing can aid in identifying HIV infections at an early stage, enabling timely medical interventions and reducing the risk of disease progression. Thus, the above-mentioned benefits of POC HIV testing equipment will increase its demand and the increasing prevalence of HIV worldwide will spur the growth of the global POC HIV testing market through the POC HIV testing equipment segment during the forecast period.
With the growing demand for medical services in the healthcare sector, diagnostic labs have grown exponentially over the years. The increased awareness among the population pertaining to the benefits of early detection of POC HIV testing, the availability of a wide range of POC HIV testing, and the growing number of healthcare settings offerings POC HIV testing are some of the major attributes that are contributing to the demand for HIV diagnostics services involving POC HIV testing. With the availability of a wide range of POC HIV testing across multiple diagnostic labs in both developed and developing nations, a rising number of people are choosing POC HIV testing. This, in turn, will drive the diagnostics lab segment and, as a result, the
For more insights about the market share of various regions View PDF Sample now!
Asia is estimated to contribute 33% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Another region offering significant growth opportunities to vendors is North America. In this region, the point of care (POC) HIV testing market has experienced major growth and innovation in recent years. The expansion of the regional POC HIV testing markets is due to advances in medical research, improved healthcare infrastructure, and increased awareness about HIV/AIDS. North America is a major market for POC HIV testing, encompassing the US, Canada, and Mexico.
Moreover, the government and non-government organizations in the US includes regular health check-ups as a part of their wellness programs, thereby augmenting the demand for POC HIV testing which in turn propels the POC HIV testing market growth.Furthermore, the Get Tested website service provided by the Centers for Disease Control and Prevention (CDC) enables people to find fast, free, and confidential testing centres near their desired locations in the US. The search tool on the website allows users to find desired locations and clinics with the help of area zip codes, thereby providing people with information about HIV testing locations. Such factors are expected to drive the market in this region during the forecast period.
In 2020, the COVID-19 pandemic severely impacted the regional POC HIV testing market. Due to the temporary suspension of diagnostic services as well as procedures, the pandemic led to a decline in the use of POC HIV testing in regional healthcare facilities which negatively impacted the point of care (POC) HIV testing market. Nevertheless, the initiation of COVID-19 vaccination and the lifting of lockdown restrictions led to the gradual resumption of various clinical procedures, which were postponed. As a result, there is an increase in demand for POC HIV testing in Q1 2021 due to the resumption of regular diagnostic services and treatments in North America. Therefore, the regional POC HIV testing market is expected to experience growth during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Abbott Laboratories - The company offers POC HIV testing such as Determine HIV 1 or 2 AG Combo.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
The rise in awareness programs for HIV testing is an emerging trend shaping the market growth. The provision of HIV counselling and testing plays an imperative part in growing awareness of HIV, as it has a higher probability of declining the rate of new infections. With the aim to prevent the spread of HIV, several national and international organizations have been set up across the globe. For instance, the American Institutes for Research (AIR) is a not-for-profit organization that works toward bringing the most effective ideas and approaches to enhance the quality of life. In order to integrate HIV testing into primary health care, it offers healthcare professionals a variety of instruments and resources.
However, such a strategy incorporates three major goals such as the reduction of new HIV infections, expanding access to care for people living with HIV, and lowering HIV-related health threats. Therefore, the growing awareness about HIV infection and its subsequent treatment through several government and private organizations have resulted in higher adoption of POC HIV testing, thereby will drive the market growth during the forecast period.
Limited healthcare services in developing and underdeveloped nations is a significant challenge hindering the market growth. A large population in developing regions such as Asia-Pacific, the Middle East, and Africa neither access to healthcare facilities nor have adequate knowledge about health concerns. Such a trend is prevalent due to a lack of financial and human resources, which is a significant barrier to public health promotion, hence rising the HIV-infected population. Developing countries such as Algeria, Kenya, Afghanistan, and Bangladesh lack technology, infrastructure, and adequate policies to deliver efficient healthcare services.
Also, many people have a stigma related to HIV testing due to a lack of education, such as the misconception that HIV is not a serious threat and embarrassment about a physical examination. This leads to the avoidance of HIV testing and treatment of HIV. The prevalence of HIV causes high rates of mortality and morbidity, and a lack of financial resources for infrastructure and health facilities may impede market growth during the forecast period.
Buy Now Full Report and Discover More
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global POC HIV Testing Market Customer Landscape
The POC HIV testing market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
POC HIV Testing Market Scope |
|
Report Coverage |
Details |
Page number |
150 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 2.91% |
Market growth 2023-2027 |
USD 290.77 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
2.65 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
Asia at 33% |
Key countries |
US, Germany, France, UK, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, AltraTech Ltd., Becton Dickinson and Co., binx health inc., bioMerieux SA, Cochrane, Community Pharmacy England, CVS Health Corp., Danaher Corp., DrSafeHands, F. Hoffmann La Roche Ltd., Island Health, J. Mitra and Co. Pvt. Ltd., MH Sub I LLC, Orchard Healthcare Pvt. Ltd., OraSure Technologies Inc., SHINE SA, Walter de Gruyter GmbH, Yashoda Hospitals, and bioLytical Laboratories Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.